	Health-related Problems and Lived Experiences of Breast Cancer Survivors: A Mixed-Methods Study. Indian J Palliat Care Kaur M, Yadav BS, Dahiya D, Kaur S, Sharma A, Ghoshal S. PMID: 41953831 [PubMed]
	Role of Electro-Therapeutic Modalities in Breast Cancer-Related Lymphedema and Shoulder Dysfunction: A Systematic Review and Meta-Analysis. Indian J Palliat Care Pattanshetty R, Shrestha A, Pawar N. PMID: 41953826 [PubMed]
	A perspective on precision therapeutics in polycystic ovary syndrome: integrating multi-omics, AI-driven stratification, and emerging biologics. Front Endocrinol (Lausanne) Pinton P. PMID: 41953703 [PubMed - indexed for MEDLINE]
	FCGR2B (+) Macrophages as a Critical Node Linking Ferroptosis and Immunosuppression: A Multiomics Framework for Prognosis and Therapy in High-Grade Serous Ovarian Cancer. Hum Mutat Zhou J, Zeng T, Liu Y, Ye M, Li M, Zhang Z, Meng Y. PMID: 41953398 [PubMed - indexed for MEDLINE]
	Impact of Adjuvant Chemotherapy on Survival Outcomes in Intermediate- and High-Risk ER+/HER2- Breast Cancer Stratified by Genomic Profiling: A Meta-Analysis. Int J Breast Cancer Seabrook M, Navas ASM, Francis HM, Aladili Z, Rao A. PMID: 41953376 [PubMed]
	Effectiveness of self-management interventions in reducing cancer treatment-related cardiotoxicity in breast cancer survivors: A systematic review. Asia Pac J Oncol Nurs Yang M, Yang Q, Tse G, Ma Y, Lyu QY, Wang W, Lai AY, Zhang Y, Wong CWM, Liu X. PMID: 41953236 [PubMed]
	Comparative efficacy and safety of individual short-acting versus long-acting granulocyte colony-stimulating factors, including biosimilars, for primary prophylaxis of chemotherapy-induced myelosuppression in breast cancer patients: a systematic review and network meta-analysis protocol. Front Oncol Bi X, Shu S, Tang K, Yin P, Chen Y. PMID: 41952689 [PubMed]
	Characteristics and influencing factors of sleep disturbance in breast cancer patients: a cross-sectional study. Front Oncol Xie Y, Wang Y, Fang Y, Zhu G, Sui B, Yuan X, Chen Y, Li M, Fan W, Zhang Y. PMID: 41952683 [PubMed]
	Do Not Overlook Me: Breast Cancer in Appalachian Women Ages 28-49 Diagnosed Through A Mobile Mammogram Unit (MMU) Program. Eur J Breast Health Heidel RE, King LM, Allen S, Bell JL. PMID: 41952465 [PubMed]
	The Role of Structured Exercise in Breast Cancer Survivorship. Eur J Breast Health Mohamed BMA, Paluskievicz C, Bean C, Buderer N, Jacobs L, Sogunro OA. PMID: 41952460 [PubMed]
	Improving Adherence to National Guidelines Regarding Neoadjuvant Systemic Therapy in the Management of Breast Cancer: A Single-Institution Quality Improvement Initiative. Eur J Breast Health Beeghly S, Baumrucker C, Haney V, McSwain A, Teal CB. PMID: 41952456 [PubMed]
	Family History Assessment and the Impact on Breast Cancer Diagnosis. Eur J Breast Health Sutherby C, Cochenour M, Schuman S. PMID: 41952455 [PubMed]
	Predictive value of serial dynamic lipid monitoring for pathologic complete response to neoadjuvant chemotherapy in luminal breast cancer: a retrospective study integrating metabolic and clinical indicators. BMC Womens Health Zeng Y, Sun Y. PMID: 41952141 [PubMed - as supplied by publisher]
	Palbociclib in the Treatment of HR+/ HER2- Advanced or Metastatic Breast Cancer in Australia: A Real-World Retrospective Analysis. Asia Pac J Clin Oncol Nott L, Moylan E, Colosimo M, Stratton G, Chiu T, Kouhkamari MH, Hitschfeld M, Michie J, De Boer R. PMID: 41952090 [PubMed - as supplied by publisher]
	Letter to the Editor: Methodological Concerns in Bryant et al.'s Network Meta-Analysis on Residual Disease Thresholds in Advanced Ovarian Cancer. Am J Ther Saim M. PMID: 41952063 [PubMed - as supplied by publisher]
	Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer. Br J Cancer Drew Y, Gilbert L, Martinez Bueno A, Oaknin A, Moreno V, Gaba Garcia L, Jayson GC, Kristeleit RS, Lakhani N, Banerjee S, Matei D, Oza A, Miller R, Yiannakis D, Barretina-Ginesta MP, Martínez García J, Wang G, Miriyala J, Franke A, Galvez E, Pandite L, Richardson DL. PMID: 41951722 [PubMed - as supplied by publisher]
	Long-term prognostic value of ctDNA in early breast cancer: insights from the neoadjuvant ABCSG-34 Trial. NPJ Breast Cancer Egle D, Hlauschek D, Gampenrieder SP, Rinnerthaler G, Singer C, Pfeiler G, Bartsch R, Huber G, Pichler A, Petru E, Bago-Horvath Z, Kermanidis AS, Fesl C, Zhou Q, Graf R, Hammer S, Dandachi N, Filipits M, Gnant M, Heitzer E, Balic M. PMID: 41951687 [PubMed - as supplied by publisher]
	Neoadjuvant palbociclib and endocrine therapy versus chemotherapy in ERâ€‰+â€‰/HER2- breast cancer: a randomized phase II trial. Nat Commun Matikas A, Tzoras E, Sarafidis M, Sifakis EG, Bjöhle J, Barnekow E, Margolin S, Isaksson-Friman E, Kessler LE, Zouzos A, Johansson H, Hellström M, Agartz S, Grybäck P, Salgkamis D, Zerdes I, Wang K, Hartman J, Acs B, Sun W, Boyaci C, Villacampa G, Pascual T, Gavila J, Prat A, Perou C, Brandberg Y, Bergh J, Hatschek T, Foukakis T. PMID: 41951647 [PubMed - as supplied by publisher]
	Squamous Precursor Lesions of the Vulva: A Practical Approach. Dermatol Clin Crimmins J, Schneider MM, Selim MA. PMID: 41951322 [PubMed - indexed for MEDLINE]
	Addressing unmet needs in long-term survivors of ovarian cancer (ENGOT ov40/NOGGO S13/GEICO 71-R/Expression VI): insights from a Spanish cohort. Int J Gynecol Cancer Barretina-Ginesta MP, Madariaga A, Gil-Martín M, Ramchandani A, Pardo M, Sanchez-Heras AB, Churruca C, Guerra-Alia EM, Madroñal C, Fernandez-Plana J, Herrero A, Dotor E, Esteban C, Quindós-Varela M, Romeo M, Gost E, Bermejo MJ, Fernandez-Chacón C, Ferrer N, Gomez-Raposo C, Tort SC, Eichbaum M, Sehouli J, Woopen H. PMID: 41951282 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 327080

Page 1 of 16354



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy